A direct injection of 2 kinds of Ad vectors into esophageal carcinoma is technically feasible and the up-regulated p53 pathways by the combinatory Ad usage can also contribute to enhanced sensitivity to chemotherapeutic agents and radiotherapy. Here, TP53 is linked to carcinoma of esophagus.